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Abstract Structure-based mutagenesis was used to probe the
binding surface for the activation domain of sterol-responsive
element binding protein (SREBP) in the KIX domain of
CREB binding protein. A set of conserved residues scattering
in the K2 helix and the extended C-terminal region of K3 helix
in the KIX domain including two arginines previously charac-
terized as a hot spot for cofactor-mediated methylation was
shown to be crucial for SREBP^KIX interaction, and was not
essential for phosphorylated KID recognition. Therefore, our
results suggest the existence of a SREBP binding site formed
by positively charged residues in the C-terminal part of the
extended K3 helix of the KIX domain distinct from the previ-
ously identi¢ed phosphorylated KID binding site.
- 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
Key words: Sterol-responsive element binding protein;
cAMP-responsive element binding protein;
CREB binding protein; Structure-based mutagenesis ;
Protein^protein interaction; Post-translational modi¢cation
1. Introduction
The cAMP-responsive element binding protein (CREB)
binding protein (CBP) and p300 belong to a family of bridg-
ing proteins serving as general transcription co-activators with
intrinsic acetyltransferase activity [1^3]. They can connect
many DNA binding factors to the basal transcription machin-
ery via direct protein^protein interactions with the activation
domain of transcription factors, and present histone acetyl-
transferases to speci¢c nucleosomes containing the target gene
promoters to play roles in chromosome remodeling [4,5]. In-
teractions between CBP/p300 and transcriptional activators
are mediated by several conserved docking domains in the
both ends of CBP/p300. Among them, the KIX domain is
located in the N-terminal part of CBP/p300 and has been
shown to be responsible for the recruitment of at least a dozen
transcription factors [3,6^11]. For example, the KIX domain
of CBP/p300 can recruit CREB by associating with the serine
133-phosphorylated KID domain of CREB to activate CRE-
bearing gene expression in response to cAMP signals [2,6]. On
the other hand, other transcription factors, such as c-Myb,
Jun, sterol-responsive element binding protein (SREBP) and
the activation domain of mixed lineage leukemia (MLL) pro-
tein, interact with the KIX domain in a constitutive way with-
out the need for phosphorylation by kinases [7^11]. Sequence
alignment of these factors revealed no consensus KIX recog-
nition motif among them [12,13]. An interesting question is
thus how the KIX domain recognizes so many transcription
factors of di¡erent natures.
The structure of the pKID^KIX complex has been solved
[14,15]. It shows the structure of the pKID-bound KIX is
composed of three mutually interacting helices, K1, K2 and
K3 with two short bridging 310 helices, G1 and G2. The
pKID binding surface in the KIX domain is formed by a
hydrophobic groove constituted by the K1 and K3 helices.
Mutagenesis studies of the KIX domain implicated the same
hydrophobic groove as the major binding site for both CREB
and c-Myb [12], and were recently con¢rmed by nuclear mag-
netic resonance (NMR) studies [16]. No obvious sequence
similarity could be found in the regions responsible for KIX
binding by CREB and c-Myb although the spacing patterns of
critical hydrophobic residues in these regions are similar [12].
Phage display selection of small peptides capable of compet-
ing with pKID for KIX domain binding also revealed a sim-
ilar spacing pattern of amphipathic nature [17]. Together with
the results of thermodynamic analysis for the binding process-
es of CREB and c-Myb toward the KIX domain, it was pro-
posed that the KIX domain bound an amphipathic helix
formed by either the pKID of CREB or the activation domain
of c-Myb although the mechanisms underlined the binding
was di¡erent between these two ligands [12,16]. However, re-
cent NMR chemical shift mapping analysis of the MLL-
bound and p-Jun-bound KIX indicated the existence of a
distinct binding surface for MLL and p-Jun recognition in
addition to the amphipathic helix binding surface for CREB
docking [18,19]. It thus raises the possibility that there exist
distinct ligand binding pockets for other KIX binding ligands
[18,19]. In this work, structure-based mutagenesis in combi-
nation with in vitro binding assays will be used to show di¡er-
ent sets of residues in the KIX domain of CBP are essential
for CREB and SREBP binding respectively. Furthermore,
two conserved arginines required for SREBP binding identi-
¢ed in this work may participate in a recently explored post-
translational modi¢cation circuit that could lead to the regu-
lation of SREBP-mediated gene expression.
2. Materials and methods
2.1. Plasmids
The genes encoding the KIX domain of human CBP (KIX98, con-
taining residues 586^683), the KID domain of human CREB (KID60,
containing residues 86^145) and the minimal KIX binding region of
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human SREBP (SREBP29, containing residues 17^45) were con-
structed by a polymerase chain reaction (PCR)-based ligation ap-
proach [20]. Each gene was assembled from di¡erent pieces of chemi-
cally synthesized DNA oligonucleotides that cover the open reading
frame of the gene of interest. Long partially overlapping oligonucleo-
tides with sequences taken from both strands of the gene of interest
were designed and the DNA sequences in some codons were changed
to encode the favored codons used in bacteria to facilitate expression
(see Table 1 for the designed DNA sequences used in the PCR-based
ligation). Recombinant expression vectors for KID60 and SREBP29
were obtained by sub-cloning the gene fragments obtained from
PCR-based ligation into the BamHI/EcoRI sites of the pGEX-4T1
expression vector (Pharmacia). These recombinant pGEX-KID60
and pGEX-SREBP29 were then used to express glutathione S-trans-
ferase (GST)-KID60 and GST-SREBP29 fusion proteins used in the
GST pull-down assay. The pMal-c2x expression vector (New England
Biolabs) was used as the vehicle for the construction of expression
vector for myelin basic protein (MBP)-KIX98 fusion protein. A blue-
white screen procedure was performed to identify TB1 colonies carry-
ing an insert with the desired KIX98 gene according to the instructions
of the manufacturer. The recombinant pMal fusion vectors were then
recovered and retransformed into competent BL21 (DE3) cells for
MBP-KIX98 protein expression after sequence veri¢cation. All the
mutants with point mutation in KIX98 were created using the Quick-
Change site-directed mutagenesis kit (Stratagene) according to the
manufacturer’s instructions with appropriate primers (the sequences
are available upon request). The identities of all cloned and mutated
genes were con¢rmed by DNA sequencing analysis.
2.2. Expression and puri¢cation of fusion proteins
Escherichia coli BL21 (DE3) cells were used as the host for the
expression of GST-tagged and MBP-tagged fusion proteins. The
transformed bacteria were grown in LB medium (enriched with
0.2% mM glucose for expressing MBP-tagged protein) in the presence
of 100 Wg/ml ampicillin to an A600 value of 0.6^0.8 at 37‡C. Ex-
pression of proteins was then induced by the addition of 1 mM iso-
propyl-1-thio-L-D-galactopyranoside (IPTG) and the growth of cells
was continued for another 2 or 3 h for MBP-tagged or GST-tagged
proteins respectively. The cells were then collected by centrifuga-
tion and suspended in phosphate-bu¡ered saline (PBS) bu¡er (10
mM Na2HPO4, 1.8 mM KH2PO4, 140 mM NaCl, 2.7 mM KCl, 0.2
mM phenylmethylsulfonyl £uoride (PMSF), pH 7.3) for storage at
380‡C.
For the puri¢cation of expressed proteins, the frozen cell pellets
containing expressed GST fusion proteins were thawed and sonicated
in the presence of 1 mM PMSF. The cell lysates were centrifuged and
the clari¢ed lysates were then applied into a pre-packed glutathione-
agarose bead column (Pharmacia) equilibrated with PBS bu¡er. After
extensive washing with 25 column volumes of PBS bu¡er, the GST-
tagged proteins were eluted with 1 column volume of elution bu¡er of
50 mM Tris^HCl and 10 mM reduced glutathione at pH 8.0. The
fractions containing eluted fusion proteins (checked by sodium dodec-
yl sulfate^polyacrylamide gel electrophoresis (SDS^PAGE) and Coo-
massie brilliant blue staining) were pooled and dialyzed against bu¡er
containing 10 mM Na2HPO4, 10 ng/ml pepstatin and 1 mM PMSF of
pH 8.0 for 12 h at 4‡C and stored as separate aliquots at 380‡C. The
protein purity was examined by SDS^PAGE, while the protein con-
centration was measured using the Bradford assay (Bio-Rad). The
phosphorylation of KID60 was performed on the GST-KID60 fusion
protein in the presence of protein kinase A (Pharmacia) using the
conditions described by Parker et al. [6].
2.3. GST pull-down assay
The GST fusion proteins used in the pull-down assay were puri¢ed
as described above and about 15 Wg of GST-pKID60 or 35 Wg of GST-
SREBP29 was used for each pull-down reaction. The input levels of
MBP-KIX98 and MBP-KIX98 mutants within the cell extracts were
checked using SDS^PAGE by comparing with pre-puri¢ed standard
calibrated by the Bradford assay, and were estimated to be around 50
Wg per reaction. Cell extracts expressing MBP-KIX98 or its mutants
were incubated with GST-, GST-pKID60- or GST-SREBP29-bound
beads in binding bu¡er (20 mM HEPES, pH 7.5, 150 mM NaCl,
1 mM EDTA, 1 mM dithiothreitol, 0.1% PMSF and 10% glycerol)
for 90 min at 4‡C. The beads were then washed ¢ve times with ice-
cold binding bu¡er, and the complex-containing beads were re-sus-
pended in 2USDS loading bu¡er and resolved by 12% SDS^PAGE.
The resolved protein bands were visualized by either Coomassie bril-
liant blue staining or Western blotting following a standard procedure
using anti-MBP antibody (Santa Cruz Biotechnology). All the GST
pull-down experiments for each mutant were performed at least three
times with the same conclusion.
2.4. Quantitative analysis of in vitro binding e⁄ciency
The amount of protein pulled down in the GST pull-down experi-
ment can be calculated by analyzing the resolved protein bands on
SDS^PAGE stained with Coomassie brilliant blue. To do so, the
intensity of each stained protein band was scanned and measured
by an infrared imaging system, Odyssey (Li-Cor), and compared
with that of a standard to estimate the quantity of the protein in
the band of interest. The accuracy of this approach was ¢rst con-
¢rmed using a bovine serum albumin (BSA) standard calibrated by
the Bradford assay. Puri¢ed GST fusion proteins were calibrated with
the BSA standard to make a stock solution of 1 Wg/Wl and samples of
a series of diluted GST fusion protein were then analyzed by SDS^
PAGE. After being extensively destained by the destaining solution
after Coomassie brilliant blue treatment, the gel was scanned by the
imaging system to record the intensity of each band. The results were
then analyzed by Odyssey imager software and compared with the
theoretical dilution factor as well as the result obtained in the
Bradford assay. A good correlation between the theoretical dilution
factor and the calculated factor from Odyssey analysis was obtained
for a dilution factor of 10 for protein quantities in the range of 0.2^
2 Wg.
To evaluate the e¡ect of each KIX98 mutant on binding of either
GST-pKID60 or GST-SREBP29, the binding e⁄ciency of each KIX98
mutant toward pKID60 or SREBP29 was calculated by analyzing the
SDS^PAGE gel used to resolve the eluted bound proteins in the GST
pull-down experiment as described in Section 2.3. The measured in-
tensity of a protein band corresponding to a speci¢c KIX98 mutant
was divided by that corresponding to the wild-type KIX98 control
resolved in the same gel to get a relative binding ratio for each
KIX98 mutant. As can be seen, variation occurs among wild-type
and mutant KIX98 for the eluted GST fusion protein detected in
the SDS^PAGE gel. To calibrate this variation, the amount of the
GST fusion protein co-eluted with a speci¢c KIX98 mutant was di-
vided by that co-eluted with the wild-type KIX98 resolved in the same
gel to get a normalization factor for each mutant. We then divided the
relative binding ratio by the normalization factor for each mutant to
Table 1
The sequences for the designed DNA oligonucleotides used to construct the genes encoding CBP586683/KIX98, CREB101160/KID60, and
SREBP1745/SREBP29 by PCR-based ligation
KIX-1 5P-CCGAGAATTCACTGGTGTACGCAAAGGCTGGCATGAACACGTAACTCAGGACCTTCGTAGCCATCTGGT-3P
KIX-2 5P-TGAGAGCTGCTGGATCTGGAGTCGGGAAGATTGCTTGTACCAGTTTGTGTACCAGATGGCTACGAAGGTC-3P
KIX-3 5P-TCCAGATCCAGCAGCTCTCAAGGATCGTCGCATGGAGAACCTGGTAGCGTATGCTAAGAAAGTGGAGGGC-3P
KIX-4 5P-TGCGAGCAGGTGATAGTATTCATCACGGGAGTTCGCAGACTCGTACATATCGCCCTCCACTTTCTTAGCAT-3P
KIX-5 5P-GAATACTATCACCTGCTCGCAGAGAAGATTTACAAGATTCAGAAGAACTGGAAGAGAAACGCCGTTCTC-3P
KIX-6 5P-CCGATTCTCGAGTCATGGCTGGTTGCCCAGGATGCCTTGCTTATGCAGACGAGAACGGCGTTTCTCTTCC-3P
KID-1 5P-CGATGCACATATGCAGATTTCTACTATCGCAGAATCCGAGGATAGCCAGGAGTCCGTAGACTCCGTT-3P
KID-2 5P-TAGCTCGGGCGACGAGACAGGATCTCACGGCGTTTCTGAGAATCGGTAACGGAGTCTACGGACTCCTGG-3P
KID-3 5P-CTGTCTCGTCGCCCGAGCTACCGCAAGATCCTGAACGACCTGTCCTCTGACGCACCAGGTGTACCAC-3P
KID-4 5P-GTATTCGGATCCTTAGGTTTCCTCTTCAGACTTTTCTTCCTCGATACGTGGTACACCTGGTGCGTCA-3P
SREBP-1 5P-TAGCGTGGATCCGAACTGGGTGAGCTGGACGCAGCTCTGCTGACCGACATCGAAGATATGCTCCAAC-3P
SREBP-2 5P-CAGGGAATTCAGCTAACCTGGGAAGTCGGAATCCTGGTTGTTAATCAGTTGGAGCATATCTTCGATGT-3P
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get the ¢nal binding e⁄ciency of each KIX98 mutant, presented as a
percentage of the value of wild-type KIX98 with the wild-type value
set at 100. During this calculation, we assumed that all KIX98 mutants
and the wild-type KIX98 have the same molecular weight.
2.5. Three-dimensional model mapping
The results of binding e⁄ciency analysis for each KIX98 mutant
were mapped into the 3D model of a KIX domain built upon the
published pKID-bound KIX structure [14]. A mutated residue that
resulted in a mutant with a binding e⁄ciency below 30% of that of the
wild-type KIX98 was assigned as essential for binding, whereas those
that fell between 30% and 60% were assigned to be critical for bind-
ing. The 3D model containing 90 residues (residues 587^676) was
generated based on the published mouse KIX domain structure [14]
using the program O [21]. Because the atomic coordinates for the
C-terminal residues from 668 to 676 are not available from the pub-
lished structure, residues 668^671 were modeled as an extension of the
K3 helix to adopt the helical conformation as reported [15]. Since no
information on the local conformation is available for residues 672^
676, this region was thus modeled as a coil. No molecular dynamic
simulation was applied to this model.
3. Results
3.1. Comparison of the minimal region responsible for KIX
binding in SREBP with those in CREB and c-Myb reveals
both similar and di¡erent features
Sequence comparison of the minimal domains required for
Fig. 1. Comparison of the regions required for KIX binding between CREB and SREBP. A: Sequence alignment for the minimal KIX binding
regions of CREB and SREBP shows a dramatic di¡erence in the nature of the charge for the polar side chains. Positively charged residues are
shaded while negatively charged residues are underlined. B: Conserved hydrophobic residues (labeled with dots on the top) with a ¢xed spacing
pattern can be found for the regions required for KIX binding in CREB, c-Myb and SREBP. C: Helical wheel prediction indicates the exis-
tence of a predicted amphipathic helix for the KIX binding regions of CREB, SREBP and c-Myb respectively. D: A ribbon diagram of the
NMR structure of the KIX^pKID complex [14] with the conserved hydrophobic groove for CREB docking formed by the parallel K1 and K3
helices of KIX facing the viewer. The gray ribbons represent the KIX domain while the black ribbons belong to pKID with their constituent
secondary structures shown as indicated.
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KIX binding between SREBP, KID and c-Myb indicated a
dramatic di¡erence in the nature of the charge for the polar
side chains between CREB119146 and SREBP1745. Two
thirds of the polar side chains in CREB119146 are positively
charged, whereas there are only negatively charged ones in
SREBP1745 (Fig. 1A). On the other hand, the spacing of
the conserved hydrophobic residues does show a similar pat-
tern among the KIX binding regions of CREB, SREBP and
c-Myb, suggesting they may dock into the same hydrophobic
groove in KIX (Fig. 1B,C). However, mutational studies on
SREBP indicated that some interactions important for pKID^
KIX recognition were not required for SREBP^KIX interac-
tion although the hydrophobic residues did contribute to the
binding [22]. Furthermore, replacement of the key residues in
KID involving direct KIX binding with a stretch of six non-
conserved residues, DIEDML in SREBP, led to the formation
of a chimeric KID capable of binding CBP with high a⁄nity,
suggesting the binding mechanisms of pKID and SREBP to
KIX might not be identical [22]. Finally, circular dichroism
spectroscopy of the minimal KIX binding region of SREBP,
SREBP29, revealed a random coil content similar to that of
KID (data not shown), and very di¡erent from the reported
30% helical content for c-Myb although both SREBP and
c-Myb bound to KIX in a phosphorylation-independent way
Fig. 2. In vitro binding assay of GST-pKID60 and GST-SREBP29 toward wild-type and mutant KIX98. A: Schematic representation of KIX98
with the residues mutated for study in bold. Please note that this construct contains 11 extra residues in the C-terminal end (these residues are
underlined) compared with the construct derived from mouse CBP used for NMR study [15]. Since there is a one-residue shift between the
mouse and human KIX, residue 625 in this KIX98 construct will thus correspond to residue 624 in the NMR construct and the numbering dif-
ference is also applicable to all the other residues. B: Results of 12% SDS^PAGE for GST pull-down assay between GST-pKID60 and MBP-
KIX98 variants (as indicated at the top of each well) stained with Coomassie brilliant blue. The smaller fragments below GST-pKID60 belong
to degraded products of GST-pKID60. C: Western blotting result for B using the antibody against MBP. D: Results of 12% SDS^PAGE anal-
ysis for GST pull-down assay between GST-SREBP29 and MBP-KIX98 variants (as indicated at the top of each well) stained with Coomassie
brilliant blue. The bands at the top of the gel with a dashed arrow correspond to the dimerized GST fusion protein as revealed by Western
blotting using anti-GST antibody (data now shown). E: Western blotting result for D using the antibody against MBP. All the GST pull-down
experiments for each mutant were performed at least three times with the same conclusion.
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[12]. Together, these results prompted us to examine if the
KIX domain uses the same pKID binding surface to recognize
SREBP.
3.2. Mutations in key residues in the KIX domain involving
direct contact with pKID lead to a dramatic loss of pKID
binding e⁄ciency in the in vitro binding assay
Structure-based mutagenesis provides a rational way to de-
sign mutants for functional studies because it helps avoid
mutants with global conformational change that can generate
data di⁄cult to interpret. Up to date, there is no structural
information available for the interaction between SREBP and
KIX. With the pKID^KIX complex structure (Fig. 1D), we
reasoned that a parallel comparison of the binding e⁄ciency
between phosphorylated KID and SREBP toward wild-type
and mutants of the KIX domain using an in vitro binding
assay should provide valuable information regarding the rec-
ognition of SREBP by the KIX domain. Therefore, we cre-
ated a series of KIX mutants using the published KIX^pKID
complex structure as a guide to avoid mutants that might
impair the formation of the hydrophobic core of KIX. Several
residues known to contact the pKID directly and other con-
served residues on the surface of KIX were the major targets
of mutagenesis. In total, we obtained 20 di¡erent point mu-
tants of a 98-residue KIX domain derived from human CBP,
KIX98 (Fig. 2A) that can be expressed successfully with a
reasonable yield. All these KIX mutants were expressed as
fusion proteins with a MBP tag in the N-terminal end to
facilitate characterization by Western blotting using the anti-
body against MBP.
We then used a KID domain derived from human CREB,
KID60, as a test to examine the e¡ects of di¡erent KIX98
mutants on pKID60 binding and compared the results with
the published complex structure and mutagenesis studies [12^
15] with focus on mutants with reduced binding a⁄nity. As
shown in Fig. 2B,C, the KIX98 mutants for three key residues
in the KIX domain involving CREB binding (K607A, Y659A
and K663A) [13,14] all show dramatically reduced amounts of
pulled-down products compared with the wild-type KIX98
against the phosphorylated GST-KID60. Particularly, the re-
duced binding ability of mutant K663A, which was reported
to have a 25-fold decrease in pKID binding a⁄nity compared
with the wild-type KIX, might not be fully appreciated, but it
can be easily identi¢ed in our system [13,14]. In addition, ¢ve
KIX98 mutants with reduced pKID60 binding a⁄nity are new
from this study. Among them, the results for H603A, R647A
and H652A can be explained as the result of mutation in
residues directly contacting pKID based on the analysis of
the published NMR structure. On the other hand, the ob-
served reduction in pKID60 binding for mutants K590A and
H593A of KIX98 is probably caused by perturbation of intra-
molecular contacts within KIX. In the published structure,
H593 was found to interact with R589 in stabilizing the G1
helix, whereas K590 could interact with S643 and N645 in the
loop between the K2 and K3 helices of KIX to help organize
their relative orientation. Mutation of H593 and K590 in the
G1 region may thus perturb the local conformations that
eventually lead to the recon¢guration of the CREB docking
surface. Interestingly, most of the remaining KIX98 mutants
resulted in an increase of binding a⁄nity for pKID60. Togeth-
er, these results indicate a good correlation between the direct
contact residues and the impairment of e⁄cient pKID60 bind-
ing in our assay, arguing that this approach can be used to
search for critical residues in the KIX domain involving li-
gand binding.
3.3. Mutants on the surface of KIX with severe impairment of
SREBP binding are mapped to a distinct region of the
CREB docking site
We then applied the same procedure to look for the muta-
tions on KIX that lead to an impairment of e⁄cient SREBP29
binding; the results are presented in Fig. 2D,E. In comparing
Fig. 3. Evaluation of the binding e⁄ciency for di¡erent KIX98 mutants against pKID60 and SREBP29. The calculated GST-pKID60 (striped
bars) and GST-SREBP29 (¢lled bars) binding e⁄ciency of di¡erent MBP-KIX98 mutants compared with the wild-type MBP-KIX 98 is pre-
sented. The ligand binding e⁄ciency of wild-type KIX98 is set as 100% and the schematic secondary structures that each mutated residue be-
longs to are shown at the top. The data were analyzed by performing volume integration of the bands corresponding to the pulled-down
MBP-KIX98 variants, GST-pKID60 and GST-SREBP29, using the Odyssey imaging system (Li-Cor) and analyzed by Odyssey software with
procedures described in Section 2. The plotted values are the means of three independent experiments, and the error bars are S.D.
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the results with those from the KID60 binding assay (Fig.
2B,C), a broader distribution of KIX98 mutants with strongly
a¡ected SREBP binding ability is observed. Importantly, the
mutated residues with severe impairment in SREBP29 binding
e⁄ciency (R625A, K635A and R672A) do not overlap with
those residues essential for the binding of pKID60 (K607A,
Y659A and K663A). It thus provides compelling evidence that
residues directly contacting pKID do not appear to perform
an essential role in the interaction with SREBP. Among the
three residues crucial for SREBP binding, R672 in the C-ter-
minal end of the extended K3 helix was previously thought to
play a role, together with other positively charged residues
nearby, in the stabilization of the hydrophobic core by neu-
tralizing the negative helix dipole with their positively charged
side chains [15]. Our results thus assign this conserved residue
an extra role in the interaction with SREBP. Most interest-
ingly, this R672 and the R625 in the N-terminal end of the K2
helix were also found to be the favored targets for post-trans-
lational methylation by CARM1 in a recent study [23]. There-
fore, a possible transcriptional switch similar to that for
CREB mediated by cofactor methylation may also exist for
SREBP.
To further evaluate the e¡ects of each KIX98 mutant on
pKID60 and SREBP29 binding, we quanti¢ed the impact of
each mutant on ligand binding by comparing the amount of
bound KIX98 mutant with bound wild-type KIX98 toward a
normalized amount of pKID60 or SREBP29 (see Section 2 for
details). As shown in Fig. 3, the residues critical for pKID
binding are clustered in the K1 helix and the N-terminal part
of the K3 helix. In contrast, the residues important for SREBP
binding are located in the K2 helix and the extended C-termi-
nal region of the K3 helix. We also noticed that K590 and
H593 in the G1 region of KIX exhibit a dramatic reduction in
SREBP binding e⁄ciency. However, a substantial reduction
in pKID binding was also observed for mutation on these two
residues. As K590 and H593 may participate in the intramo-
lecular interactions that organize the tertiary fold of KIX as
mentioned in Section 3.2, this impairment in ligand binding
e⁄ciency may thus be an indirect outcome of the disruption
of critical tertiary interactions caused by mutation. Consistent
with this interpretation, no intermolecular contact between
the G1 region of KIX and pKID can be observed in the
published complex structure [14]. We then mapped these re-
sults into a modi¢ed 3D structure of pKID-bound KIX to
generate structural models displaying the critical regions in-
volving pKID60 or SREBP29 binding respectively (Fig. 4). In
the structural model, K607, Y659 and K663, which are essen-
tial for pKID binding, are mapped to the parallel K1 and K3
helices that form the CREB docking groove (Fig. 4A). On the
other hand, the residues most critical for SREBP binding, that
Fig. 4. Structural models for the location of KIX residues critical for SREBP binding. A: Models showing the parallel K1 and K3 helices of
KIX that form the CREB docking groove with the residues critical for pKID60 (left) and SREBP29 binding (right) mapped into the models.
This view is the same as that in Fig. 1D except that pKID is removed and extra residues are added to the C-terminal end of KIX. B: Models
showing the surface formed by the K2 helix of KIX (turned 180‡ from the view in A) with the residues critical for pKID60 (left) and SREBP29
binding (right) mapped into the models. Residues that lead to a reduction of binding e⁄ciency upon mutation are assigned to be essential for
binding if the binding e⁄ciency falls below 30% of that of the wild-type KIX and are shown in dark blue. In contrast, residues are assigned as
critical for binding if the binding e⁄ciency falls between 30% and 60% of that of the wild-type KIX; they are shown in light blue color. (For
interpretation of the references to color in this ¢gure legend, the reader is referred to the web version of this article.)
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is, R625 and K635 in the K2 helix and R672 in the K3 helix,
are located on the opposite side of the conserved hydrophobic
groove for CREB docking, arguing for the existence of a
distinct binding surface for SREBP (Fig. 4B).
4. Discussion
As part of e¡orts to elucidate the molecular mechanisms for
the versatile transcriptional activator binding activity of the
KIX domain of CBP, we used structure-based mutagenesis in
combination with in vitro binding assays to probe the SREBP
recognition surface of KIX. Since all the mutants that lose
most of their SREBP binding abilities retain substantial
CREB binding a⁄nity, it is unlikely that the observed reduc-
tion in SREBP binding ability is caused by global mis-folding
of the mutants. Our results thus clearly demonstrate that the
pools of residues essential for CREB and SREBP binding are
di¡erent, implying distinct binding sites in the KIX for these
two transcription activators. Particularly, the positively
charged residues located in the C-terminal region of the K3
helix represent a unique binding surface for SREBP (see the
upper left corner in the right panel of Fig. 4B) as they have
been shown to be dispensable for phosphorylated KID bind-
ing [15]. Together with R625 in K2 helix (the upper right
corner in the right panel of Fig. 4B), this patch of positively
charged residues can potentially gate the groove that is en-
circled by the extended K3 helix and the N-terminal part of
the K2 helix although the conformation of the extended K3
helix remains unknown. However, we cannot rule out the
possibility of overlap between the binding sites for pKID
and SREBP due to the limitation in resolution because the
numbers of mutants are not exhaustive. Besides, the local
conformations for SREBP-bound KIX may be di¡erent
from those for pKID-bound KIX that we know. Further-
more, residues in the K2 helix region (R625 and K635) do
show some minor e¡ects on pKID60 binding although they
appear to be absolutely required for SREBP29 binding, where-
as Y659, crucial for pKID binding, also a¡ects the binding of
SREBP substantially, implying a dual role for these residues
in the recognition of both ligands. Intriguingly, we also no-
ticed overlap between residues critical for SREBP binding in
our studies and the residues involving MLL and p-Jun bind-
ing probed by NMR chemical shift mapping analysis [18]. For
example, R625, crucial for SREBP binding, also exhibits a
large chemical shift change upon the formation of MLL^
KIX or p-Jun^KIX complex [18,19]. The NMR mapping re-
sults also indicated that residues scattered around G2 pos-
sessed the biggest chemical shift perturbation upon addition
of MLL or p-Jun. Unfortunately, the number of available
mutants (D623 and R625) in this region is limited in our study
and it will await the 3D structure of the complex between
SREBP and KIX to resolve these in detail.
As mentioned earlier, a major di¡erence between KID and
SREBP in sequence identity is the opposite nature of the
charge of the side chains. The existence of a group of posi-
tively charged side chains essential for SREBP binding thus
raises the possibility that electrostatic interactions may play
an important role in the interaction between SREBP and
KIX. However, the elucidation of the nature of this interac-
tion will need more work. Finally, the ¢nding that both R625
and R672 are hot spots for CARM1 methylation [23] may
deserve further investigation because a post-translational
modi¢cation by CBP with lysine acetylation in the DNA bind-
ing domain of SREBP has also been reported recently [24].
Since this acetylation can lead to the stabilization of SREBP,
a modi¢cation by methylation of arginine residues critical for
CBP^SREBP interaction may thus serve to regulate the me-
tabolism of SREBP post-translationally.
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